A pilot study of NY-ESO-1c259 T cells in subjects with advanced myxoid/round cell liposarcoma (NCT02992743).

Authors

null

Sandra P. D'Angelo

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Sandra P. D'Angelo , Mihaela Druta , George D. Demetri , David A. Liebner , Scott Schuetze , Arun S. Singh , Neeta Somaiah , Brian Andrew Van Tine , Breelyn A. Wilky , Karen Chagin , Tim Pulham , Malini Iyengar , Elliot Norry , Arundathy N. Bartlett-Pandite , Rafael G. Amado

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research,Immunotherapy

Sub Track

Cellular Immunotherapy

Clinical Trial Registration Number

NCT02992743

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS3097)

DOI

10.1200/JCO.2017.35.15_suppl.TPS3097

Abstract #

TPS3097

Poster Bd #

189a

Abstract Disclosures

Similar Posters